Drop Patient Bloodwork
Drag & drop a lab PDF here, or click to upload
🧬
SAGE · BLOOD ANALYSIS ENGINE
0%
Initializing...
✓ ANALYSIS COMPLETE · APR 11 2026 · LIFELABS
AMARO, NICO ANDREW
Male · 31 years · DOB Jul 27 1994 · Lab #26-255101041
0
Health Score
OVERALL: EXCELLENT
Panel Summary
22
Markers in Range
1
Borderline
0
Out of Range
23
Total Markers
Hematology · Complete Blood Count
General Chemistry
Electrolytes & Organ Function
Hormonal & Endocrine Panel
Surgical Risk Assessment
Pre-Operative Risk Profile · AMARO, Nico Andrew
Assessment based on LifeLabs panel dated Apr 11 2026 · Reviewed by SAGE AI
LOW
OVERALL SURGICAL RISK
🩸 Bleeding Risk
LOW
Platelets208 ✓
Hematocrit0.49 ✓
Hemoglobin162 g/L ✓
RBC (borderline)5.52 ⚠
Platelet count and coagulation markers are within safe operative thresholds. Marginally elevated RBC is non-concerning and may provide slight oxygen-carrying advantage intraoperatively.
💉 Anesthesia Safety
LOW
eGFR (drug clearance)98 ✓
Creatinine90 µmol/L ✓
ALT (liver)36 U/L ✓
Sodium140 mmol/L ✓
Potassium4.4 mmol/L ✓
Renal and hepatic function excellent. Anesthetic agents will metabolize and clear normally. Electrolyte balance is optimal — no cardiac rhythm risk associated with induction.
🦠 Infection & Immune Risk
LOW
WBC4.9 ✓
Neutrophils2.4 ✓
Lymphocytes1.6 ✓
Monocytes0.4 ✓
Eosinophils0.4 ✓
No signs of active infection or suppressed immunity. Neutrophil and lymphocyte counts support normal post-operative immune response. No prophylactic antibiotics required beyond standard protocol.
🩹 Wound Healing
LOW RISK
Glucose (fasting)5.2 mmol/L ✓
HbA1c5.7% ⚠
Testosterone18.3 nmol/L ✓
Albumin (est. via eGFR)Normal ✓
HbA1c at 5.7% is within normal but approaches the pre-diabetic threshold — tissue perfusion and healing should not be significantly affected. Testosterone at 18.3 nmol/L supports tissue repair and collagen synthesis. Expected healing: above average.
❤️ Cardiovascular
LOW
Potassium4.4 mmol/L ✓
Sodium140 mmol/L ✓
Hematocrit0.49 ✓
TSH (thyroid)1.03 mU/L ✓
Electrolyte profile is balanced with no arrhythmia risk markers. Thyroid function is normal — no concerns regarding intraoperative hemodynamic instability. Hematocrit supports adequate tissue oxygenation.
⚗️ Endocrine / Hormonal
FAVORABLE
TSH1.03 mU/L ✓
Testosterone18.3 nmol/L ✓
Estradiol57 pmol/L ✓
LH2.8 IU/L ✓
Hormonal axis is balanced and fully functional. No perioperative steroid supplementation required. Testosterone levels are an active healing asset. No stress-response hormonal dysfunction anticipated.
Cleared for surgery. All critical pre-operative thresholds met. No contraindications identified from this panel.
Monitor HbA1c trend in future panels. Current value (5.7%) is within range but warrants periodic tracking given proximity to pre-diabetic threshold (5.7–6.4%).
RBC mildly elevated at 5.52 — confirm patient hydration status day-of. No transfusion preparation required.
Standard nil-by-mouth protocol applies. No special glycemic management required given fasting glucose of 5.2 mmol/L.
Renal clearance (eGFR 98) supports full standard anesthetic and analgesic dosing without adjustment.
Recommend repeat bloodwork if surgery is scheduled more than 90 days from this panel date (Apr 11 2026).
No surgical contraindications identified. Patient presents as an excellent surgical candidate across all assessed domains. Bleeding, anesthetic, healing, cardiovascular, and endocrine risk profiles are all low. Proceed with standard pre-operative protocol.